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ABSTRACT
Introduction The Global Burden of Disease Study
2010 estimated the worldwide health burden of 291
diseases and injuries and 67 risk factors by calculating
disability-adjusted life years (DALYs). Osteoporosis was
not considered as a disease, and bone mineral density
(BMD) was analysed as a risk factor for fractures, which
formed part of the health burden due to falls.
Objectives To calculate (1) the global distribution of
BMD, (2) its population attributable fraction (PAF) for
fractures and subsequently for falls, and (3) the number
of DALYs due to BMD.
Methods A systematic review was performed seeking
population-based studies in which BMD was measured
by dual-energy X-ray absorptiometry at the femoral neck
in people aged 50 years and over. Age- and sex-speciﬁc
mean ± SD BMD values (g/cm2) were extracted from
eligible studies. Comparative risk assessment
methodology was used to calculate PAFs of BMD for
fractures. The theoretical minimum risk exposure
distribution was estimated as the age- and sex-speciﬁc
90th centile from the Third National Health and
Nutrition Examination Survey (NHANES III). Relative risks
of fractures were obtained from a previous meta-
analysis. Hospital data were used to calculate the
fraction of the health burden of falls that was due to
fractures.
Results Global deaths and DALYs attributable to low
BMD increased from 103 000 and 3 125 000 in 1990 to
188 000 and 5 216 000 in 2010, respectively. The
percentage of low BMD in the total global burden
almost doubled from 1990 (0.12%) to 2010 (0.21%).
Around one-third of falls-related deaths were attributable
to low BMD.
Conclusions Low BMD is responsible for a growing
global health burden, only partially representative of the
real burden of osteoporosis.
INTRODUCTION
Osteoporosis is a skeletal disorder characterised by
compromised bone strength predisposing to an
increased risk of bone fractures.1 Osteoporotic frac-
tures are deﬁned as those occurring as the result of a
low-impact trauma, with consequences ranging from
chronic pain to institutionalisation and death.2–8 For
people over 50 years of age living in a developed
country, the lifetime risk of sustaining any fracture is
∼50% for women and 20% for men.9 Bone strength
primarily reﬂects the integration of bone mineral
density (BMD) and bone quality. The latter is
awkward to assess on a population basis, while BMD
is a well-deﬁned predictor of fracture risk10 11 and is
easily measurable. For a clinical approach, osteopor-
osis is deﬁned by a threshold of 2.5 SDs below the
mean BMD value of the young reference.12 13
However, the risk of fracture due to reduced BMD is
gradual over a continuum.
This paper follows the comparative risk assess-
ment (CRA) methodology in the Global Burden of
Disease (GBD) Study 2010.14 The two primary
outcome measures for the GBD work are deaths
and disability-adjusted life years (DALYs), which
combine the years lived with disability (YLDs) and
the years lost due to premature mortality (years of
life lost due to premature mortality (YLLs)).15
Burden estimates were made for 291 diseases and
injuries.15 The burden arising from 67 risk factors
was estimated by determining population attribut-
able fractions (PAFs).14 Osteoporosis per se was not
considered as a disease, and, for the ﬁrst time,
BMD was included in the global burden estimates
as a risk factor for fractures, which represented a
proportion of the global burden from falls. We
summarise the methods used to calculate the con-
tribution of low BMD to the burden of fractures
due to falls and present estimates by age and sex by
world region. We also document trends in attribut-
able burden between 1990 and 2010. Estimates of
burden were limited to populations aged 50 years
and older, as osteoporotic fractures represent little
burden at younger ages in the general population.
This report is part of the Musculoskeletal Expert
Group series within the GBD 2010 Initiative.14–18
Extended reports on the overall methods,19 global
burden of osteoarthritis,20 rheumatoid arthritis,21
gout,22 low back pain,23 neck pain,24 occupation-
ally related low back pain,25 other musculoskeletal
conditions26 and ﬁnal conclusions27 have also been
published.
METHODS
Deﬁnition of the exposure variable
We performed a systematic review of Medline,
Embase, CAB Abstracts, CINAHL, WHOLIS and
SIGLE databases for population-based studies pub-
lished from 1980 to 2010 with BMD values in
g/cm2 measured by dual-energy X-ray absorpti-
ometry (DXA) at the femoral neck (FN). In regions
with limited data, we also included other types of
study (eg, non-population-based) as long as the
sample was considered to be representative of the
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Figure 1 Summary for the Systematic
Review for Low Bone Mineral Density
as a Risk Factor. (A) Flowchart for the
systematic review process. Exclusion
criteria: A, subsample not
representative of the population (ie,
athletes); B, non-population-based
studies (ie,clinical-based); C, no
prevalence/incidence data; D, only
subtypes of osteoporosis assessed (ie,
steroid-induced osteoporosis); E,
sample number <150; F, reviews. Final
list of manuscripts used for BMD as
the exposure variable can be found in
Appendix 1, supplementary online ﬁle.
(B) Search strategies for the systematic
review. Search strategies are shown for
BMD as the exposure variable (search
strategy 1) and BMD as a risk factor
for fractures (search strategy 2). *The
whole list of the world countries was
used as Subject Headings (SH) in
Medline, Embase, CINAHL and CAB
abstracts. GBD, global burden of
disease; BMD, bone mineral density.
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national population. Central DXA is the most validated tech-
nique for measuring BMD.12 13 The location at the FN is justi-
ﬁed by the evidence that the morbidity and mortality related to
hip fracture (the osteoporotic outcome with the highest burden)
is better predicted when BMD is measured at the FN rather
than the spine or forearm.11 Furthermore, measurement at the
FN has been found to correlate well with vertebral and other
osteoporotic fractures.11
Data extraction and processing
A database was developed and implemented in MS Excel, and
information was extracted from included studies into the follow-
ing predetermined ﬁelds for the exposure variable: region,
country, year of publication, study type, study sample size,
population description, coverage, urbanicity (rural, urban or
both), start year of data collection, last year of data collection,
age group start, age group end, sex, ethnicity, DXA manufac-
turer, DXA FN-speciﬁc coefﬁcient of variation, and mean BMD
value in g/cm2 and SD.
All mean BMD and SD values with different DXA manufac-
turers (mainly Hologic, Norland and Lunar) were standardised
using an international conversion formula28 to standardise mean
BMD (sBMD) and SD (sSD).
Finally, a systematic data-cleaning process was performed to
identify double-counted data and inconsistencies in the values.
Search strategies and results of the systematic review for the
exposure variable are shown in ﬁgures 1A,B and 2, respectively.
Modelling strategy
Eligible articles were assessed for bias using a modiﬁed version
of a validated Risk of Bias (RoB) tool29 developed for preva-
lence studies and adapted for osteoporosis.30 For selection bias,
the risk was considered low when most recruited subjects were
included, moderate when only healthy subjects were included,
and high when subjects with prior fractures were excluded. The
RoB tool was not found to have signiﬁcant predictive value,30
and, consequently, all studies after the data-cleaning process
were included.
As data were available for only selected country–time periods,
the mean sBMD and sSD was estimated separately for all country–
time periods using DisMod-MR, a Bayesian meta-regression tool
developed speciﬁcally for GBD 2010.17 The model included ﬁxed
effects for study-speciﬁc covariates, and random effects by GBD
super-region, region and country. Study-speciﬁc covariates
accounted for inconsistencies in the raw data—for example, data
that were subnational (rather than nationally representative), or
data that were collected in a non-gold-standard way (eg, non-
population based). National-level covariates can be used in the
model to inform the global and country-level trends, and are not
study-speciﬁc; lag-distributed income per capita, mean body mass
index, and availability of milk based on the Food and Agriculture
Organization of the United Nations disappearance data (imports
plus local production minus exports) were tested. None of these
demonstrated a signiﬁcant improvement in the predictive ability of
the model and were therefore not included.
RELATIVE RISK ASSESSMENT: PAF OF LOW BMD TO
FRACTURES
Effect size estimates
The estimates of relative risk (RR) for fractures were based on a
meta-analysis of 12 population-based studies from Western
Europe, USA, Canada, Japan and Australia published in 2005.11
This study reported age- and sex-adjusted RRs for hip and
non-hip fractures attributable to BMD. Our systematic review
process also included searches for longitudinal population-based
studies with data on RR of fracture related to FN BMD
(ﬁgure 1). Data were heterogeneous in terms of BMD location
measurement, fracture outcome and study design. Only eight
relevant prospective studies31–38 published since 2005 were
found, with RR estimates similar to those published in the previ-
ous meta-analysis.11
The estimates of the gradient of risk (RR/SD) for BMD
Z-scores, based on the combined data for men and women,
were obtained from the authors of the meta-analysis.11 The
Z-score was established within each study population separately,
which made the RRs dependent on the spread within the study
1 - 31
32 - 62
63 - 93
94 - 124
125 - 155
156 - 186
Figure 2 Number of data points of mean bone mineral density at the femoral neck measured by dual-X-ray absorptiometry by each of the 21 GBD
world regions. All years (1980–2010), all ages, both sexes. Regions in white have no data. GBD, global burden of disease.
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population. For our purposes this was undesirable, and therefore
the ‘relative’ RR/SD values were converted into ‘absolute’ RR/
0.1 g/cm2 values (table 1) using a weighted average of the
spread in BMD values for the populations that were represented
in the meta-analysis, as they were estimated in the DisMod-MR
output, and so derived risk estimates for men and women separ-
ately by 5-year age group.
Theoretical minimum risk exposure distribution and
calculation of PAF
Comparative risk assessment (CRA) methodology14 39 was used
to estimate the proportion of fractures that are attributable to
age- and sex-speciﬁc levels of BMD analysed as a continuous
variable. CRA estimates are based on a counterfactual exposure
distribution that would result in the lowest population risk that
is theoretically possible, referred to as the theoretical minimum
risk exposure distribution (TMRED).40 The sex- and age-
speciﬁc 90th percentile from the Third National Health and
Nutrition Examination Survey (NHANES III),41 the most
broadly accepted standard international reference,13 was
chosen as the TMRED (table 2). The SD of the TMRED was
estimated on the basis of the relationship between means and
SDs from a regression of all studies in the ﬁnal dataset that
measured means and SDs of BMD.
Using the exposure distributions and the RR for fracture by
BMD level deﬁned above, PAFs were calculated42 for hip frac-
tures, non-hip vertebra fractures (fractures of vertebra occurring
without hip fracture) and non-hip fractures, using the following
formula:
PAF ¼
Ðm
x¼0 RR(x)P(x)dx
Ðm
x¼0 RR(x)P'(x)dxÐm
x¼0 RR(x)P(x)dx
where RR(x) is the RR at exposure level x, P(x) is the popula-
tion distribution of exposure, P0(x) is the counterfactual distribu-
tion of exposure, and m the maximum exposure level.
HEALTH BURDEN OF FRACTURES AS A FRACTION OF FALLS
For attributing deaths to low BMD, the difﬁculty is that deaths
are categorised according to cause of injury (ie, falls), not nature
of injury (ie, fracture), and low BMD or osteoporosis is not
coded as a cause. Fractures can be found as a consequence of
many events such as road accident, assault or natural disasters.
For the purposes of this analysis, estimates were restricted to
fractures due to falls, where we expected most osteoporotic frac-
tures to be coded. It was necessary to turn to hospital data from
Brazil,43 Canada,44 Mexico45 and the USA46 47 to estimate the
fraction of in-hospital deaths from falls that involved hip and
vertebra fractures. Those with a mention of concurrent head or
internal injury were excluded. Other fracture types were also
excluded, as these were considered less likely to lead to death,
as supported by an analysis of the Australian mortality data-
base.48 Among those inpatient deaths where the primary cause
for admission was a fall, a large fraction, especially at older ages,
involved a hip fracture; only a small proportion of deaths asso-
ciated with a vertebral fracture were not also associated with a
hip fracture (table 3). As this was the only data source used to
determine the fraction of deaths from falls due to hip fracture
or vertebra fracture, it was necessary to apply these age- and
sex-speciﬁc proportions to falls to every country.
Disability from falls is estimated by the nature of the asso-
ciated injury, and therefore the short- and long-term disability
was estimated for fractures by site. The RRs for hip fracture
Table 2 Theoretical-minimum-risk exposure distribution (TMRED)
for men and women aged 50 years and over
Age Mean sBMD SD
Women
50–59 1.00 0.14
60–69 0.92 0.14
70–79 0.84 0.13
80+ 0.78 0.13
Men
50–59 1.09 0.16
60–69 1.06 0.16
70–79 1.02 0.16
80+ 0.98 0.16
Values are expressed in g/cm2 and correspond to the age- and sex-specific 90th
centile of the mean BMD from NHANES III41 after internationally recognised
standardisation.28
sBMD, standardised bone mineral density.
Table 3 Fraction of in-hospital deaths from falls involving hip and
vertebra fractures
Sex Age Hip fracture (%) Non-hip vertebra fracture (%)
Women 50–59 61.6 2.6
60–69 73.2 1
70–79 79.4 0.6
80+ 82.5 0.5
Men 50–59 46 8
60–69 67.5 4.6
70–79 79.8 0.9
80+ 84.2 0.4
Percentages express the fraction of in-hospital deaths from falls that involve hip
fractures and non-hip vertebra fractures (deaths from vertebral fractures that occur
without hip fracture). Calculated with in-patient hospital data from Brazil,43 Canada,44
Mexico45 and the USA.46 47
Table 1 Relative risk (RR) of hip and non-hip fractures for each
0.1 g/cm2 decrease in bone mineral density (BMD)
Age (years)
RR/0.1 BMD unit decrease
Non-hip fractures Hip fractures
Mean LCI HCI Mean LCI HCI
Men
50–54 1.152 1.058 1.254 2.603 2.042 3.319
55–59 1.183 1.104 1.268 2.421 1.978 2.961
60–64 1.215 1.147 1.286 2.282 1.938 2.689
65–69 1.249 1.189 1.311 2.177 1.914 2.478
70–74 1.297 1.238 1.357 2.100 1.897 2.324
75–79 1.338 1.279 1.402 1.921 1.781 2.072
80+ 1.371 1.302 1.444 1.730 1.627 1.840
Women
50–54 1.158 1.061 1.265 2.697 2.096 3.470
55–59 1.201 1.114 1.296 2.629 2.109 3.278
60–64 1.237 1.162 1.317 2.466 2.062 2.951
65–69 1.286 1.216 1.358 2.412 2.084 2.792
70–74 1.342 1.274 1.413 2.315 2.064 2.596
75–79 1.398 1.327 1.475 2.118 1.942 2.311
80+ 1.438 1.355 1.526 1.878 1.750 2.016
Values are RR of fracture per each 0.1 unit of BMD decrease. Units of BMD are g/cm2.
Adapted from Johnell et al.11
LCI, lower 95% CI; HCI, high 95% CI.
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(table 1) were applied to the YLD estimates for hip fracture due
to falls sub-cause. The RRs for non-hip fracture (table 1) were
applied to YLD estimates for all other fracture sites known to be
associated with osteoporosis (clavicle, scapula, humerus, skull,
sternum, rib, face bone, radius or ulna, femur, patella, tibia,
ﬁbula, ankle, pelvis, vertebral, other extremities). Details on the
disability weights for fracture types and methods used to calcu-
late YLDs due to falls can be found elsewhere.17 18
RESULTS
There were 130 eligible articles (Appendix 1, supplementary
online ﬁle), with a total of 860 data points from 49 countries
and 17 world regions (ﬁgure 2). Worldwide distributions of
mean BMD for people aged 50 years and over for 1990 and
2010 are shown in ﬁgure 3. Asia and Africa were the world
regions with the lowest values of BMD at the FN, while high-
income North America, Caribbean and Eastern Europe showed
the highest BMD values for both men and women. Although
age-adjusted data showed an improving trend for BMD values
over time,49 especially in Asia and Western Europe, BMD at a
population level decreased in some regions as a result of the
ageing of the population.
For all diseases, injuries and risk factors, data on DALYs, YLDs,
YLLs and deaths can be seen online by region, country, year,
Figure 3 Word distribution of standardised bone mineral density in g/cm2 at the femoral neck at country level. (A) Men, 1990; (B) women, 1990;
(C) men, 2010; (D) women, 2010.
Figure 4 World distribution of disability-adjusted life years (DALYs) for low bone mineral density per 100 000 population at country level. All ages,
both sexes. (A) Estimations for 1990; (B) estimations for 2010 (for all estimations for 1990, 2005 and 2010 for men and women at country, region
and super-region levels, please visit http://www.healthmetricsandevaluation.org/gbd/visualizations/country).
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age and sex (http://www.healthmetricsandevaluation.org/gbd/
visualizations/country). Global deaths and DALYs attributable to
low BMD increased from 103 000 and 3 125 000 in 1990 to
188 000 and 5 216 000 in 2010, respectively (table 4). The per-
centage of low BMD in the total global burden almost doubled
from 1990 (0.12%) to 2010 (0.21%) (table 4). The fraction of the
total regional burden increased in all regions except the Caribbean
and Oceania. Asia East and South were the major contributors to
the increase in global burden of low BMD. Rates of global DALYs
per 100 000 population increased markedly from 1990 to 2010,
but the increase was modest after age standardisation (table 5),
which reﬂects population growth and ageing. Rates were higher in
Western Europe, Central Europe and high-income Asia Paciﬁc
(ﬁgure 4 and table 5), while the highest age-standardised rates were
more commonly found in developing regions such as Sub-Saharan
Africa East and West, Oceania, Asia East and South (table 5).
The PAFs of BMD for falls were generally higher for women
than men for both 1990 and 2010. In general, world regions
with a low gross domestic product showed the highest PAFs (Asia
East and South-East, North Africa-Middle East, Sub-Saharan
Africa East and West), with the exception of Eastern Europe.
However, big disparities in PAFs were observed among high-
income countries, even within the same world region—for
example, Scandinavian countries compared with UK (ﬁgure 5).
In 1990, global DALYs and deaths attributable to low BMD
constituted 12.1% and 29.6% of all falls-related DALYs and
deaths, respectively. These percentages increased slightly to
14.8% and 34.7% for 2010 estimates. Table 6 shows percen-
tages of the falls burden due to low BMD by world region.
Low BMD ranked low in terms of attributable DALYs com-
pared with most risk factors, such as dietary factors, high blood
pressure, smoking, alcohol use, high fasting plasma glucose, high
body mass index, high cholesterol and low physical activity
(http://www.healthmetricsandevaluation.org/gbd/visualizations/
gbd-heatmap). Globally, low BMD ranked 23rd among 25 risk
factor categories for 2010 (dietary risk factors clustered into one
category and occupational risk factors clustered into one cat-
egory). By region, the highest ranks for low BMD were observed
in Western Europe and high-income Asia Paciﬁc, ranked 12th
and 13th, respectively, followed by Central Europe, Australasia
and high-income North America at 15th and Asia East at 16th.
DISCUSSION
Although age-adjusted data showed an improving trend of the
global BMD values over time, the absolute burden of low BMD
increased from 1990 to 2010, probably related to the global
growth of the aged population. Higher age-standardised rates of
DALYs and higher PAFs in developing regions probably reﬂect
the importance of the potentially modiﬁable determinants of
low BMD (such as nutritional factors and access to healthcare).
Low BMD could be responsible for at least one-third of deaths
attributable to falls, which is third in the list of major health
burdens after road injuries and self-harm, as reported previ-
ously.15 However, the contribution of low BMD to the global
health burden compared with other risk factors was low, and it
is likely that the burden of osteoporosis has been underesti-
mated for several reasons.
First, the choice of an age- and sex-speciﬁc TMRED masked
the important role of age and sex in fracture risk,50 and it may
explain in part the lower health burden of BMD compared with
other risk factors. Given that the gradient of risk of fracture for
each unit of BMD decrease is the same in men and women,11
the use of the young female reference seems reasonable in clin-
ical settings. In the GBD framework, however, risk factor
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Table 5 Rates of DALYs per 100 000 population by GBD region in 1990 and 2010
Location
1990 2010
All ages Age-standardised All ages Age-standardised
Asia Pacific, high-income 80.79 (59.46 to 106.37) 65.85 (48.44 to 86.62) 138.31 (102.67 to 181.06) 63.43 (47.48 to 82.93)
Asia, Central 38.02 (26.64 to 50.90) 54.17 (37.79 to 72.72) 37.46 (26.80 to 52.41) 49.41 (35.15 to 69.01)
Asia, East 68.64 (56.02 to 84.10) 94.54 (77.36 to 116.21) 92.00 (72.58 to 113.50) 86.45 (68.28 to 106.73)
Asia, South 44.15 (32.85 to 59.10) 86.92 (65.52 to 115.84) 64.87 (42.01 to 88.54) 102.87 (66.89 to 140.05)
Asia, Southeast 45.39 (35.50 to 55.66) 85.71 (66.39 to 104.44) 62.48 (46.36 to 77.96) 84.81 (62.64 to 105.55)
Australasia 87.20 (60.27 to 124.09) 69.28 (48.18 to 98.00) 117.27 (79.24 to 164.28) 67.52 (44.60 to 94.86)
Caribbean 48.02 (35.73 to 60.13) 66.22 (49.20 to 83.01) 62.56 (46.94 to 79.73) 66.16 (49.74 to 84.60)
Europe, Central 154.51 (121.21 to 192.20) 121.69 (95.48 to 151.15) 187.81 (141.40 to 245.17) 108.44 (82.07 to 142.07)
Europe, Eastern 60.65 (39.77 to 86.20) 45.32 (29.78 to 64.35) 85.59 (54.13 to 118.30) 54.61 (34.90 to 75.23)
Europe, Western 140.64 (108.32 to 181.16) 83.04 (63.72 to 107.39) 183.26 (140.75 to 239.56) 85.86 (65.50 to 112.71)
Latin America, Andean 35.06 (25.74 to 45.51) 67.45 (49.50 to 87.44) 36.57 (27.09 to 48.39) 50.41 (37.37 to 66.73)
Latin America, Central 27.00 (21.75 to 33.29) 51.84 (41.80 to 63.95) 35.65 (28.15 to 43.87) 47.45 (37.43 to 58.41)
Latin America, Southern 63.37 (44.87 to 86.13) 64.96 (45.86 to 88.32) 63.86 (45.05 to 87.23) 50.92 (35.90 to 69.74)
Latin America, Tropical 29.45 (21.24 to 39.82) 52.47 (37.74 to 70.95) 56.82 (37.06 to 75.07) 63.95 (41.54 to 84.41)
North Africa/Middle East 30.78 (23.18 to 40.86) 66.54 (50.20 to 88.00) 37.45 (27.85 to 49.71) 60.63 (45.36 to 80.72)
North America, high-income 43.48 (28.23 to 59.15) 31.57 (20.62 to 42.99) 70.82 (43.07 to 99.00) 41.83 (25.21 to 58.36)
Oceania 56.02 (39.92 to 76.49) 147.40 (106.54 to 199.03) 41.21 (30.75 to 55.27) 91.17 (69.18 to 118.80)
Sub-Saharan Africa, Central 30.92 (23.39 to 39.60) 77.97 (59.17 to 99.77) 27.08 (20.45 to 35.20) 73.34 (55.58 to 95.12)
Sub-Saharan Africa, Eastern 37.20 (29.19 to 48.64) 96.50 (75.27 to 125.60) 42.24 (28.34 to 53.42) 103.90 (69.87 to 131.93)
Sub-Saharan Africa, Southern 15.51 (10.70 to 21.08) 36.91 (25.43 to 50.07) 22.20 (15.40 to 30.10) 38.17 (26.33 to 51.75)
Sub-Saharan Africa, Western 46.15 (37.28 to 56.03) 114.76 (92.56 to 138.91) 44.07 (36.03 to 52.63) 108.31 (87.83 to 130.19)
Global 58.95 (48.83 to 71.89) 77.89 (64.51 to 94.96) 75.71 (59.99 to 93.15) 79.87 (63.28 to 98.22)
Values with 95% CIs are rates of DALYs per 100 000 population. All ages, both sexes. Age standardisation was obtained using the global standard proposed by the WHO in 2001
(http://www.who.int/healthinfo/paper31.pdf).
DALYs, disability-adjusted life years; GBD, global burden of disease.
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Figure 5 Age-standardized population attributable fraction (PAF) of low bone mineral density for falls. Values are expressed on 0–1 scale. (A)
Men, 1990; (B) women, 1990; (C) men, 1990; (D) women, 2010. Age standardization was obtained using the global standard proposed by the WHO
in 2001 (http://www.who.int/healthinfo/paper31.pdf ).
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Table 6 Burden of low bone mineral density as a percentage of falls-related burden by GBD region and year
Region
1990 2010
DALYs YLLs YLDs Deaths DALYs YLLs YLDs Deaths
Asia Pacific, high income 16.3 (13.6 to 19.3) 21.7 (18.8 to 25.8) 14.4 (11.4 to 17.6) 38.0 (33.3 to 42.9) 22.3 (18.8 to 25.8) 38.2 (32.1 to 42.6) 18.1 (14.7 to 21.5) 50.5 (44.3 to 55.6)
Asia, Central 8.0 (6.4 to 9.4) 4.9 (4.1 to 5.6) 9.7 (7.4 to 11.9) 12.7 (10.9 to 14.3) 8.5 (6.9 to 10.1) 6.0 (4.7 to 7.3) 9.7 (7.6 to 11.7) 14.0 (11.6 to 16.3)
Asia, East 13.7 (11.6 to 15.6) 14.6 (11.5 to 16.9) 12.7 (10.4 to 15.0) 32.8 (27.8 to 36.7) 17.5 (15.2 to 20.0) 21.8 (18.6 to 25.7) 14.1 (11.7 to 16.7) 39.7 (35.4 to 44.6)
Asia, South 8.9 (7.0 to 11.0) 9.1 (7.0 to 11.5) 8.7 (6.2 to 11.1) 21.6 (17.5 to 25.8) 11.9 (9.0 to 14.8) 13.7 (10.1 to 17.8) 9.2 (6.7 to 11.7) 28.3 (21.8 to 34.4)
Asia, Southeast 13.8 (11.6 to 16.2) 17.7 (14.0 to 21.6) 10.5 (8.7 to 12.4) 35.3 (30.3 to 40.8) 16.3 (13.6 to 19.1) 23.2 (19.3 to 26.8) 11.3 (9.3 to 13.3) 40.1 (35.1 to 44.9)
Australasia 15.0 (11.1 to 18.7) 27.2 (21.6 to 32.3) 12.7 (9.1 to 16.4) 40.5 (30.5 to 48.2) 17.3 (12.9 to 21.5) 35.2 (27.3 to 41.6) 14.3 (10.3 to 18.2) 44.3 (32.6 to 52.7)
Caribbean 13.6 (10.7 to 16.3) 19.0 (14.7 to 22.9) 9.4 (7.3 to 11.6) 36.8 (28.2 to 43.7) 12.6 (9.7 to 15.3) 24.8 (19.3 to 29.7) 8.3 (6.3 to 10.4) 40.3 (29.5 to 48.4)
Europe, Central 18.9 (16.0 to 21.8) 26.4 (23.2 to 29.4) 14.6 (12.0 to 17.5) 39.9 (34.2 to 44.7) 20.0 (16.9 to 23.2) 32.0 (28.1 to 35.2) 16.0 (13.2 to 19.0) 43.1 (37.1 to 47.8)
Europe, Eastern 11.1 (7.7 to 14.4) 13.8 (9.6 to 17.3) 9.7 (6.4 to 13.0) 24.0 (16.9 to 29.9) 12.7 (8.7 to 16.0) 16.1 (11.0 to 20.2) 10.3 (6.7 to 13.6) 25.9 (17.9 to 32.3)
Europe, Western 18.5 (15.8 to 21.3) 30.9 (27.0 to 34.8) 14.4 (12.1 to 16.6) 40.9 (34.6 to 46.7) 20.1 (17.0 to 23.1) 36.8 (32.5 to 40.6) 16.1 (13.4 to 19.1) 43.7 (37.1 to 48.9)
Latin America, Andean 9.3 (7.4 to 11.2) 9.6 (7.6 to 11.6) 9.1 (6.9 to 11.5) 23.4 (19.2 to 27.3) 11.7 (9.2 to 13.9) 13.4 (10.9 to 15.8) 10.8 (8.0 to 13.5) 30.2 (24.8 to 34.6)
Latin America, Central 11.0 (9.5 to 12.5) 11.4 (10.0 to 13.1) 10.5 (8.4 to 12.6) 27.5 (24.4 to 30.7) 14.7 (12.5 to 16.9) 18.7 (15.5 to 21.2) 11.5 (9.4 to 13.6) 36.1 (31.5 to 40.1)
Latin America, Southern 14.3 (10.9 to 17.5) 20.1 (16.2 to 23.8) 12.1 (8.6 to 15.6) 37.3 (29.8 to 43.1) 15.3 (12.0 to 18.7) 26.2 (21.1 to 30.8) 12.8 (9.8 to 16.0) 42.0 (33.1 to 49.0)
Latin America, Tropical 11.3 (9.1 to 13.6) 11.2 (9.0 to 14.0) 11.4 (8.8 to 14.2) 26.8 (21.8 to 32.1) 17.1 (12.9 to 20.8) 22.6 (15.8 to 27.2) 13.6 (10.3 to 16.8) 40.0 (31.7 to 46.9)
North Africa/Middle East 8.6 (7.3 to 10.0) 5.6 (4.2 to 7.0) 10.5 (8.8 to 12.2) 17.1 (13.6 to 20.7) 10.5 (9.1 to 11.9) 8.9 (7.8 to 10.3) 11.2 (9.4 to 13.1) 23.2 (20.8 to 26.0)
North America, high income 13.5 (9.4 to 17.4) 24.1 (17.3 to 30.2) 8.7 (5.7 to 11.6) 34.9 (23.1 to 43.7) 17.2 (11.4 to 22.7) 31.3 (21.8 to 39.1) 10.5 (7.0 to 13.8) 38.0 (25.0 to 47.1)
Oceania 10.2 (8.1 to 12.5) 9.2 (6.4 to 12.4) 10.8 (8.4 to 13.4) 20.9 (16.1 to 26.2) 10.7 (8.3 to 13.0) 11.6 (7.8 to 15.7) 10.0 (7.7 to 12.1) 24.5 (18.1 to 30.5)
Sub-Saharan Africa, Central 6.9 (4.0 to 12.0) 6.0 (2.6 to 14.3) 9.5 (7.4 to 11.7) 16.2 (8.7 to 30.7) 7.1 (4.6 to 11.0) 6.3 (3.1 to 13.0) 9.3 (7.3 to 11.4) 16.7 (9.9 to 28.7)
Sub-Saharan Africa, East 9.4 (6.2 to 13.1) 9.6 (5.4 to 15.0) 9.4 (7.8 to 11.0) 24.2 (15.9 to 32.0) 12.0 (9.0 to 14.4) 13.1 (8.8 to 16.2) 9.6 (8.0 to 11.4) 29.7 (22.8 to 33.9)
Sub-Saharan Africa, Southern 9.6 (7.2 to 11.8) 14.7 (11.3 to 18.2) 8.0 (5.9 to 10.2) 31.0 (24.5 to 37.1) 10.7 (8.4 to 13.1) 17.6 (13.8 to 21.7) 8.8 (6.5 to 11.0) 34.9 (28.0 to 41.3)
Sub-Saharan Africa, West 5.1 (3.3 to 9.1) 4.1 (2.6 to 8.7) 10.9 (8.9 to 13.0) 13.9 (9.8 to 23.1) 6.7 (5.1 to 9.0) 5.7 (4.1 to 8.4) 10.8 (9.0 to 12.6) 18.3 (14.0 to 23.7)
Global 12.1 (11.1 to 13.2) 12.7 (11.3 to 14.7) 11.5 (10.3 to 12.8) 29.6 (27.4 to 32.0) 14.8 (13.4 to 16.0) 17.3 (15.4 to 19.1) 12.7 (11.4 to 13.9) 34.7 (32.2 to 37.1)
Values with 95% CI represent low bone mineral density burden expressed as the percentage of falls-related burden. All ages, both sexes.
DALYs, disability-adjusted life years; YLDs, years lived with disability; GBD, global burden of disease; YLLs, years of life lost due to premature mortality.
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analysis focuses on modiﬁable risk factors. The TMRED should
be possible at the population level and supported by convincing
epidemiological evidence of a continuous risk reduction to that
exposure distribution.16 Longitudinal studies51 52 have demon-
strated that a small percentage of older people can maintain
their bone mass over time in the absence of risk factors for
osteoporosis. However, the extent to which the differences in
BMD observed by age and sex are modiﬁable is not certain.
Men have a higher BMD than women, women show faster rates
of bone loss after menopause than men,52–54 and there is no
deﬁnitive evidence that individuals can maintain their young
peak bone mass as they age. There is also a signiﬁcant genetic
component to the ability to retain bone mass.55 56 On the basis
of this evidence, we used a TMRED that was age- and sex-
speciﬁc. In order to enable worldwide comparisons, an inter-
national reference standard is recommended,57 and the choice
of an American reference (NHANES III) might lead to overesti-
mates or underestimates of the risk depending on the world
region. However, NHANES III is the reference used in the
meta-analysis from which we derived the risk relationship
between BMD and fractures.11 Further research into the mod-
iﬁability of BMD would help to inform the choice of TMRED.
Separating deaths due to speciﬁc fractures from overall deaths
due to falls was not straightforward. Osteoporotic fractures are
deﬁned as those occurring as the result of a low-impact trauma,
but hospital data on falls-related deaths did not include the
nature of the injury. Our review did not ﬁnd prospective popu-
lation studies with data on mortality due to falls-related frac-
tures covering both sexes and all ages over 50 years. Most of the
studies reporting deaths from falls-related fractures were carried
out retrospectively from medical charts and death certiﬁcates, or
they were restricted to frail older populations. This made it dif-
ﬁcult to determine what percentage of all falls in a population
leads to a fracture-related death.
Hip fracture and clinical vertebral fractures have been shown to
be the ﬁrst and second most important sites, respectively, for osteo-
porotic fracture-related deaths.5 58 59 For our mortality analysis,
we used in-hospital data, and other fracture types were excluded,
as they were less likely to be the underlying cause of death.
However, this may have contributed to underestimation of the
mortality burden given the evidence that other osteoporotic frac-
ture sites are related to a higher risk of long-term mortality com-
pared with age- and sex-matched peers.5 60 61 A prospective
population-based study conducted over an 18-year period in
Australia5 showed that the fall-fracture event was likely to be
missed out as an underlying cause for some deaths that occurred a
long time after the fall, particularly in non-hip and non-vertebral
fractures. However, long-term mortality after fractures is tedious
to interpret within the scope of the GBD Study. Previous studies
have demonstrated that mortality is highly related to baseline
frailty,62–65 and it is hard to estimate what percentage of the excess
mortality is really due to the fracture event.
As the exposure variable-measuring method, DXA is consider-
ably more expensive and technically more complicated than
measurement systems for other risk factors such as hypertension
or body mass index. Consequently, the availability of DXA scans
is limited,66 leading to a possible selection bias towards coun-
tries with better access to DXA scans. Selecting the FN as the
location of the fracture further restricted the number of papers
that could be included. Furthermore, the application of stand-
ardisation equations among different DXA manufacturers28 is
unlikely to have removed all differences, especially between
models from the same manufacturer.67 68 In addition, BMD has
low sensitivity in identifying fracture risk,69 being purely a
quantitative value that does not account for other mechanical
properties known to inﬂuence bone strength, and consequently
leading to an underestimation of the burden associated with
osteoporosis.
Another important limitation is selection bias in the source
studies. Most of the studies excluded subjects with a history of
fracture, bone metabolism diseases, or receiving treatments that
might affect bone metabolism. We expected to ﬁnd discrepancies
in the BMD values among different study groups depending on
the exclusion or inclusion of such subjects, but linear regression
models failed to prove this assumption. The reasons for this are
not fully apparent, but it might be related to the heterogeneity
among studies. We recommend including patients with previous
fractures or a diagnosed bone disease in similar future studies.
This is particularly important in elderly populations, as the per-
centage of individuals with a history of previous fragility frac-
tures is high and excluding such subjects makes the sample not
truly representative of the real population and underestimates the
real risk.
CONCLUSION
This analysis demonstrates that low BMD is a growing global
health burden. However, this is likely to reﬂect only a small part
of the true burden of osteoporosis, given that BMD cannot
reﬂect other important components of bone strength. For future
studies of GBD, we strongly recommend a focus on osteoporosis
as a disease rather than a risk factor. Health information systems
should be better equipped to detect fragility fractures and long-
term mortality related to them. The information provided could
be used to better inform targeted clinical and public health pre-
vention and management programmes.
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